AHA Coding Clinic® for HCPCS - 2022 Quarter 4; For Your Information
Updates to Emergency Use Authorizations for COVID-19 vaccines
The U.S. Food and Drug Administration (FDA) has authorized several amended versions of its emergency use authorizations (EUA) for the administration of COVID-19 vaccines for the prevention of COVID-19 infection. Effective Aug. 19, 2022, the EUA for the administration of the Novavax COVID-19 vaccine adjuvanted, two dose primary series, was amended to include all patients 12 through 17 years of age . Effective Aug. 31, 2022, the EUA for the administration of the Pfizer-BioNTech bivalent vaccine was amended to authorize the vaccine for patients 12 years and older . The Moderna bivalent vaccine EUA was expanded and authorized...
Subscribe or sign in to view the full article.
Article Overview
This article reviews FDA emergency use authorization updates affecting COVID-19 vaccines and the corresponding CPT coding information. It is relevant for coding professionals, billing staff, and clinicians who need to track vaccine product and administration code changes associated with age-based authorization updates. The article presents the general scope of the authorization changes and the related CPT vaccine and administration categories without serving as a full coding reference.
Why This Topic Matters
COVID-19 vaccine authorizations changed over time by manufacturer and patient age group, which can affect correct reporting of vaccine product and administration services. Keeping current with these updates helps support accurate documentation, billing, and code selection workflows.
Article Sections
-
FDA emergency use authorization updates
Overview of the authorization changes and the timeframes in which they became effective. Covers the manufacturers and age-group updates discussed in the article.
-
Emergency use authorizations for COVID-19 vaccines
Table-style summary of vaccine product and administration coding information organized by patient age and manufacturer. Presents the related CPT categories addressed in the article.
What You Will Learn
- How the article frames FDA emergency use authorization updates for COVID-19 vaccines
- Which age groups are associated with the vaccine authorization changes discussed
- How the article organizes related CPT vaccine product and administration information
- Which manufacturers are included in the update summary
Who Should Read This
- Medical coders
- Billing specialists
- Revenue cycle staff
- Clinical documentation staff
- Immunization program staff
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com